ACHE and Alzheimer disease: Acetylcholine (ACh), is a cholinergic neurotransmitter and its deficiency is responsible for the cognitive decline in AD patients which has been considered a target to designing novel agent with an AChE-inhibition profile to increase the cerebral acetylcholine level (Lane et al., 2004; Marco-Contelles et al., 2006).